« Previous
Next »
European Journal of Internal Medicine
Volume 17, Issue 7
, Pages 508-510
, November 2006
Budesonide combined with ursodeoxycholic acid in primary biliary cirrhosis with advanced liver damage
References
- . Primary biliary cirrhosis. Lancet. 2003;362:53–61
- . Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut. 2001;49:276–281
- . Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 2003;38:S24–S37
- . Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology. 2000;31:318–323
- Oral budesonide and ursodeoxycholic acid for treatment of pirmay biliary cirrrhosis: results of a prospective double-blind trial. Gastroenterology. 1999;117:918–925
- Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology. Apr 2005;41:747–752
- . Combined analysis of randomized controled trials of ursodeoxycholic acid in Primary Biliary Cirrhosis. Gastroenterology. 1997;113:884–890
PII: S0953-6205(06)00166-X
doi: 10.1016/j.ejim.2006.04.006
© 2006 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
European Journal of Internal Medicine
Volume 17, Issue 7
, Pages 508-510
, November 2006
